NJ State Employees Deferred Compensation Plan - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q1 2018$326,000
-43.4%
20,000
-55.6%
0.06%
-42.0%
Q4 2017$576,000
+4.0%
45,0000.0%0.10%0.0%
Q3 2017$554,000
+10.4%
45,000
-25.0%
0.10%
+5.3%
Q2 2017$502,000
-6.3%
60,0000.0%0.10%
-6.9%
Q1 2017$536,000
+1.7%
60,0000.0%0.10%
-2.9%
Q4 2016$527,000
+30.1%
60,0000.0%0.10%
+25.0%
Q3 2016$405,000
+89.3%
60,0000.0%0.08%
+86.7%
Q2 2016$214,000
+13.2%
60,0000.0%0.04%
+12.5%
Q1 2016$189,000
-25.3%
60,0000.0%0.04%
-23.1%
Q4 2015$253,000
-7.7%
60,0000.0%0.05%
-11.9%
Q3 2015$274,000
-36.7%
60,0000.0%0.06%
-29.8%
Q2 2015$433,000
-2.0%
60,0000.0%0.08%
-1.2%
Q1 2015$442,000
+55.6%
60,0000.0%0.08%
+54.5%
Q4 2014$284,000
+32.7%
60,0000.0%0.06%
+25.0%
Q3 2014$214,000
-21.9%
60,0000.0%0.04%
-18.5%
Q2 2014$274,000
-2.8%
60,0000.0%0.05%
-6.9%
Q1 2014$282,00060,0000.06%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 16,618,776$146,079,00012.59%
BVF INC/IL 4,986,186$43,829,0008.81%
First Light Asset Management, LLC 1,000,361$8,793,0003.86%
Crosspoint Capital Strategies, LLC 463,005$4,070,0003.62%
Consonance Capital Management LP 2,723,471$23,912,0002.63%
KOPP INVESTMENT ADVISORS LLC 219,926$1,933,0002.04%
SPHERA FUNDS MANAGEMENT LTD. 900,000$7,911,0002.00%
Orbimed Advisors 16,088,800$141,421,0001.80%
Cormorant Asset Management, LP 1,150,000$10,109,0001.36%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 2,073,680$18,227,0001.26%
View complete list of ARRAY BIOPHARMA INC shareholders